These findings indicate that depletion or inhibition of PAK1 creates a state of “FA/BRCAness” in transformed cells and represents a rational approach for expanding the utility of PARP inhibitors to FA/BRCA-proficient cancers. This evidence concerns the gene PAK1 and cancer.